CCVP

Cross-linguistic and Cross-population Verb Processing

 Coordinatore BCBL BASQUE CENTER ON COGNITION BRAIN AND LANGUAGE 

 Organization address address: PASEO MIKELETEGI 69 2
city: SAN SEBASTIAN
postcode: 20009

contact info
Titolo: Dr.
Nome: Miguel Angel
Cognome: Arocena
Email: send email
Telefono: 34943309300

 Nazionalità Coordinatore Spain [ES]
 Totale costo 222˙471 €
 EC contributo 222˙471 €
 Programma FP7-PEOPLE
Specific programme "People" implementing the Seventh Framework Programme of the European Community for research, technological development and demonstration activities (2007 to 2013)
 Code Call FP7-PEOPLE-2011-IOF
 Funding Scheme MC-IOF
 Anno di inizio 2012
 Periodo (anno-mese-giorno) 2012-11-17   -   2015-11-16

 Partecipanti

# participant  country  role  EC contrib. [€] 
1    BCBL BASQUE CENTER ON COGNITION BRAIN AND LANGUAGE

 Organization address address: PASEO MIKELETEGI 69 2
city: SAN SEBASTIAN
postcode: 20009

contact info
Titolo: Dr.
Nome: Miguel Angel
Cognome: Arocena
Email: send email
Telefono: 34943309300

ES (SAN SEBASTIAN) coordinator 222˙471.60

Mappa


 Word cloud

Esplora la "nuvola delle parole (Word Cloud) per avere un'idea di massima del progetto.

underpinnings    basque    subject    morphological    exploring    french    contrast    spanish    languages    vs    language    linguistic    cross    human    developmental    agrammatic    disorders    neurocognitive    grammatical    verb   

 Obiettivo del progetto (Objective)

'Verb processing is broadly described as being problematic in agrammatic aphasia, a medical consequence of left frontal hemisphere damage. Errors in verb processing are also observed in children with Specific Language Impairment, a developmental language learning disability. The aim of the present study, entitled “Cross-linguistic and Cross-population Verb Processing” is to collect and compare verb processing disorders in acquired (agrammatic) vs developmental (SLI) language disorders in order to determine whether they are of the same nature and to define the underlying reason for their similar symptomatologies. The data will be collected and analysed with a cross-linguistic perspective: in Basque, a language isolate which has rarely been studied in the context of language pathology, and French and Spanish, two romance languages that are part of the Indo-European family whose grammatical properties contrast with Basque (e.g. Basque is an ergative language, pro-drop with pluripersonal verb agreement, whereas French and Spanish are accusative languages with subject-verb agreement using subject and object clitics). This study will have an experimental and inductive approach by creating theoretically and linguistically based language tasks aimed at exploring the cognitive substrate of verb processing. Also, neuroimaging (event related potentials or ERPs) and eye-tracking methods will be developed to complement traditional elicitation and pen and paper tasks. In sum, the goal of this study is to contribute to research on the neurocognitive underpinnings of human language, with a specific focus on verb inflectional processing, while using the grammatical properties of Basque and their contrast with French and Spanish. The study of impaired vs normal verb processing in three languages with distinct morphological properties is particularly interesting for the exploration of neuropsychological bases of human grammar in general, and for morphological processing in particular.'

Introduzione (Teaser)

EU-funded research is exploring the neurocognitive underpinnings of human language. In particular, the focus is on verb processing, to be investigated through a study of the grammatical properties of Basque compared to those of French and Spanish.

Altri progetti dello stesso programma (FP7-PEOPLE)

ISMS (2010)

Internet-based Structural Health Monitoring System

Read More  

DENOT-EM-CI (2009)

Developing Nonlinear Tools for Environmental Modeling and Chemoinformatics

Read More  

MITOCANCERSTEM (2010)

Role of Mitochondrial Physiology in Tumor Stem Cell Resistance to Chemotherapeutics

Read More